A key concept of the program is that periventricular leukomalacia (PVL) results from ischemia/reperfusion that triggers free radical injury in vulnerable developing oligodendrocytes in perinatal white matter, and that, as a result developing oligodendrocytes die in part by apoptosis, thus resulting in decreased mature oligodendrocytes and impaired myelination. The overall hypothesis of the proposed study is that there is a specific vulnerability of developing oligodendrocytes to oxidative stress in the cerebral white matter in the period of greatest risk for PVL (24-32 weeks) which relates, at least in part, to a developmental lack of expression of antioxidant enzymes, and/or to the acquisition of iron necessary for oligodendrocyte differentiation. In baseline studies, we will determine the temporospatial maturation of oligodendrocytes in human cerebral white matter using immunocytochemical methods with markers to stage-specific oligodendrocytes, testing the hypothesis that the period of greatest risk for PVL coincides with a predominance of developing oligodendrocytes. We will also determine the developmental profile of selected antioxidant enzymes and markers of iron metabolism in human cerebral white matter using histochemistry, immunocytochemistry, and immunoblotting. Here we will test the hypotheses that antioxidant enzymes are expressed at low levels in immature white matter during the period of greatest risk for PVL, and that the appearance of markers of iron metabolism precedes the expression of antioxidant enzymes, thus denoting a developmental mismatch between potential sources of free radicals and the systems to clear them. In PVL itself, we will determine the densities of developing oligodendrocytes in white matter surrounding PVL, testing the hypothesis that there is a decrease in the density of developing oligodendrocytes, indicative of a targeted death and loss of these cells. We will also attempt to determine if developing oligodendrocytes undergo apoptosis in PVL. Finally, we will determine the involvement of selected cytokines in PVL with immunocytochemistry. The proposed studies should provide important insight into the roles of developing oligodendrocytes and factors related to oxidative stress in PVL directly within the human brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS038475-03
Application #
6565274
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$196,099
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Jantzie, Lauren L; Talos, Delia M; Jackson, Michele C et al. (2015) Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex 25:482-95
Elitt, C M; Rosenberg, P A (2014) The challenge of understanding cerebral white matter injury in the premature infant. Neuroscience 276:216-38
Xu, Gang; Takahashi, Emi; Folkerth, Rebecca D et al. (2014) Radial coherence of diffusion tractography in the cerebral white matter of the human fetus: neuroanatomic insights. Cereb Cortex 24:579-92
Haynes, Robin L; van Leyen, Klaus (2013) 12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia. Dev Neurosci 35:140-54
Lippman-Bell, Jocelyn J; Rakhade, Sanjay N; Klein, Peter M et al. (2013) AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures. Epilepsia 54:1922-32
Haynes, Robin L; Sleeper, Lynn A; Volpe, Joseph J et al. (2013) Neuropathologic studies of the encephalopathy of prematurity in the late preterm infant. Clin Perinatol 40:707-22
Selip, D B; Jantzie, L L; Chang, M et al. (2012) Regional differences in susceptibility to hypoxic-ischemic injury in the preterm brain: exploring the spectrum from white matter loss to selective grey matter injury in a rat model. Neurol Res Int 2012:725184
Kinney, Hannah C; Haynes, Robin L; Xu, Gang et al. (2012) Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol 71:397-406
Manning, Simon M; Boll, Griffin; Fitzgerald, Erin et al. (2011) The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain. Int J Dev Neurosci 29:767-73
Volpe, Joseph J; Kinney, Hannah C; Jensen, Frances E et al. (2011) The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29:423-40

Showing the most recent 10 out of 102 publications